Status:
COMPLETED
Pharmacogenomic Study (Adjuvant Chemotherapy)
Lead Sponsor:
Samsung Medical Center
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To assess the role of germline polymorphisms in xenobiotic metabolism genes in toxicity profile. To assess the role of germline polymorphisms in genes associated with DNA repair, p53 tumor suppressor...
Eligibility Criteria
Inclusion
- gastric cancer patients treated with adjuvant chemotherapy
Exclusion
Key Trial Info
Start Date :
July 10 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2013
Estimated Enrollment :
792 Patients enrolled
Trial Details
Trial ID
NCT01470404
Start Date
July 10 2008
End Date
July 10 2013
Last Update
January 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea